Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

NCT02218320 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Raltegravir
DRUG: Dolutegravir
PROCEDURE: Colonoscopy with biopsy

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]